Boden, W. E., Bhatt, D. L., Toth, P. P., Ray, K. K., Chapman, M. J., & Lüscher, T. F. (2020). Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: Why these results usher in a new era in dyslipidaemia therapeutics. Eur Heart J.
Citação norma ChicagoBoden, William E., Deepak L. Bhatt, Peter P. Toth, Kausik K. Ray, M John Chapman, and Thomas F. Lüscher. "Profound Reductions in First and Total Cardiovascular Events With Icosapent Ethyl in the REDUCE-IT Trial: Why These Results Usher in a New Era in Dyslipidaemia Therapeutics." Eur Heart J 2020.
Citação norma MLABoden, William E., et al. "Profound Reductions in First and Total Cardiovascular Events With Icosapent Ethyl in the REDUCE-IT Trial: Why These Results Usher in a New Era in Dyslipidaemia Therapeutics." Eur Heart J 2020.